8-K: Cancer Capital Corp. Changes Independent Accounting Firm

Cancer Capital Corp. has dismissed Pinnacle Accountancy Group and engaged Fruci & Associates as its new independent registered public accounting firm, effective November 30, 2023.

Summary

• Cancer Capital Corp. has changed its independent registered public accounting firm.
• The company dismissed Pinnacle Accountancy Group of Utah on November 30, 2023.
• The company engaged Fruci & Associates as its new independent registered public accounting firm, also effective November 30, 2023.
• The Board of Directors and the Audit Committee approved both the dismissal of Pinnacle and the engagement of Fruci.
• Pinnacle's reports on the company's financial statements for the fiscal years ended December 31, 2022, and December 31, 2021, did not contain any adverse opinions or disclaimers.
• There were no disagreements between Cancer Capital and Pinnacle on any accounting or auditing matters that would have required a reference in Pinnacle's report.
• Cancer Capital has requested a letter from Pinnacle to the SEC confirming the statements made in this filing.
• The company did not consult with Fruci on any matters outlined in Item 304(a)(2)(i) or (ii) of Regulation S-B prior to their engagement.

Sentiment

Score: 7

Explanation: The document indicates a routine change of auditors with no apparent issues, suggesting a neutral to slightly positive sentiment.

Positives

• The transition of auditors appears to be amicable, with no reported disagreements on accounting or auditing matters.
• Pinnacle's audit reports for the past two fiscal years did not contain any adverse opinions or disclaimers, suggesting a clean audit history.

Risks

• The change in auditors could potentially raise questions from investors or regulators, although the filing indicates a smooth transition.
• Any future disagreements with the new auditor could lead to complications in financial reporting.

Management Comments

• The Board of Directors approved the dismissal of Pinnacle and the engagement of Fruci.
• The Audit Committee also approved the dismissal of Pinnacle and the engagement of Fruci.

Industry Context

Changes in auditors are not uncommon, but they can sometimes signal underlying issues or a desire for a fresh perspective on financial reporting. In this case, the transition appears to be routine and without any apparent issues.

Comparison to Industry Standards

• The process of changing auditors is a standard practice in the corporate world, and the company appears to have followed the necessary procedures.
• The lack of disagreements with the previous auditor is a positive sign, as it suggests that the company's financial reporting practices are generally sound.
• Companies like BioMarin Pharmaceutical Inc. and Vertex Pharmaceuticals Incorporated have also changed auditors in the past, often for reasons such as rotation policies or cost considerations.

Stakeholder Impact

• Shareholders may be interested in the change of auditors, but the filing suggests a smooth transition.
• The change of auditors should not have a significant impact on employees, customers, or suppliers.

Next Steps

• Fruci & Associates will now be responsible for auditing Cancer Capital's financial statements.
• Pinnacle will provide a letter to the SEC confirming the statements made in the 8-K filing.

Key Dates

Keywords

auditor, accounting firm, independent accountant, Pinnacle Accountancy Group, Fruci & Associates, financial statements, audit, SEC, Cancer Capital Corp